We are live on
!
Find out more
SCA
Stonebridge Capital Advisors Portfolio holdings
AUM
$1.43B
1-Year Est. Return
21.98%
This Fund
S&P 500
This Quarter
Est. Return
+2.92%
1 Year Est. Return
+21.98%
3 Year Est. Return
+64.22%
5 Year Est. Return
+80.67%
10 Year Est. Return
+293.7%
AUM
$381M
AUM Growth
+$13.6M
(+3.7%)
Cap. Flow
+$4.85M
Cap. Flow
% of AUM
1.27%
Top 10 Holdings %
Top 10 Hldgs %
24.21%
Holding
169
New
8
Increased
78
Reduced
44
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.56M |
| 2 |
Microsoft
MSFT
|
+$2.27M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$723K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$384K |
| 5 |
Truist Financial
TFC
|
+$364K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UN
Unilever NV New York Registry Shares
UN
|
+$3.99M |
| 2 |
Corning
GLW
|
+$3.12M |
| 3 |
Apple
AAPL
|
+$1.24M |
| 4 |
BMS
Bemis
BMS
|
+$225K |
| 5 |
Baxter International
BAX
|
+$218K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.18% |
| 2 | Healthcare | 14.47% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Consumer Staples | 11.62% |
| 5 | Industrials | 11.43% |
Similar funds
SMA
ADL
TS
APCM
CCM
KCMH
PPC
SC
Stonebridge Capital Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Stonebridge Capital Advisors held 169 positions worth $381M, up 3.7% from $367M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Stonebridge Capital Advisors's Q2 2017 filing shows 8 new, 78 increased, 44 reduced and 5 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,604 shares worth $388K. The largest sale was Unilever NV New York Registry Shares, an estimated $3.99M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Stonebridge Capital Advisors's largest Q2 2017 buy was State Street SPDR S&P 500 ETF Trust: 1,604 shares worth $388K.
- Stonebridge Capital Advisors added most to Gilead Sciences in Q2 2017, an estimated $3.56M increase.
- Stonebridge Capital Advisors's biggest Q2 2017 reduction was Apple, cutting an estimated $1.24M.
- Stonebridge Capital Advisors fully exited Unilever NV New York Registry Shares in Q2 2017, selling an estimated $3.99M.
- Stonebridge Capital Advisors's ten largest holdings make up 24% of its $381M portfolio in Q2 2017.
- Stonebridge Capital Advisors opened 8 new positions and closed 5 in Q2 2017.
- Stonebridge Capital Advisors's portfolio value rose 3.7% quarter-over-quarter to $381M.
Based on Stonebridge Capital Advisors's 13F filing for Q2 2017, filed 15 Aug 2017.